| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13D/A |
| 16 Nov 2026 |
Form 4: Cascella Robert, Director
Received 173,000 shares as a grant or award ($262K) |
| 16 Nov 2026 |
Form 4: Cucuz Sasha, Director
Acquired 625,000 shares (Other Transaction) ($1M) · Received 370,370 shares as a grant or award ($500K) |
| 16 Nov 2026 | SCHEDULE 13D/A |
| 13 Nov 2026 |
Form 4: Chernett Jorey, 10% owner
Sold 250,804 shares ($599K) · Sold 103,959 shares ($214K) · Bought 40,000 shares ($79.6K) · 3 more |
| 12 Nov 2026 | 8-K/A: Entry into a Material Definitive Agreement; Other Events |
| 12 Nov 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
Neuronetics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Compan... |
| 12 Nov 2026 | 424B5 |
| 10 Nov 2026 | 424B5 |
| 10 Nov 2026 |
8-K: Entry into a Material Definitive Agreement
CERTAIN INFORMATIO IDENTIFIED WITH THE MARK “[***]” HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE SUCH INFORMATION IS BOTH (I) NOT MATERIAL AND (II) IS THE TYPE THAT IS PRIVATE OR CONFIDENTIAL. |
| 10 Nov 2026 | 144 |
| 04 Nov 2026 | 10-Q |
| 04 Nov 2026 |
8-K: Results of Operations and Financial Condition; Regulation FD Disclosure
MALVERN, PA., November 4, 2026 – Neuronetics, Inc. (NASDAQ: STIM) (the “Company” or “Neuronetics”), a leader in interventional mental health and provider of NeuroStar® TMS technology and direct patient care through the Greenbrook network... |
| 02 Nov 2026 |
Form 4: Chernett Jorey, 10% owner
Bought 18,000 shares ($40.9K) |
| 24 Aug 2026 | SCHEDULE 13D/A |
| 19 Aug 2026 | 144 |
| 18 Aug 2026 | 144 |
| 17 Aug 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
| 17 Aug 2026 |
Form 4: Chernett Jorey, 10% owner
Disposed of 100 Call Option (STIM 19FEB27 $5C) (Open Market Sale) ($321) · Bought 14,000 shares ($44.2K) |
| 14 Aug 2026 | SCHEDULE 13G |
Loading...